Adequan Canine Joint Injection from China
Polysulfated glycosaminoglycan injections for canine osteoarthritis, in pre-filled syringes. Disease-modifying veterinary therapeutic classified HTS 3004.90.92.01.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Rx-only status requires CVM approval verification
• Sterility certificates mandatory for injectables
• Not nutritional supplements despite joint health claims